IM HealthScience
Boca Raton
About IM HealthScience
IM HealthScience develops products to address overall health and wellness, including conditions with a high unmet medical need. IMH is the innovator of IBgard® and FDgard® for the dietary management of IBS (Irritable Bowel Syndrome) and FD (Functional Dyspepsia), respectively. In 2017, IMH added Fiber Choice®, a line of prebiotic fibers, to its product line via an acquisition. The sister subsidiary of IMH, Physician’s Seal®, provides REMfresh®, a well-known continuous release and absorption melatonin (CRA-melatonin) supplement for sleep. IMH co-markets REMfresh with Physician’s Seal.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Website: imhealthscience.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/im-healthscience-2169624 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.